Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy

[1]  F. Rutten,et al.  [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.

[2]  Giuseppe Limongelli,et al.  A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.

[3]  S. Colan,et al.  Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry , 2013, The Lancet.

[4]  M. Link,et al.  Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. , 2013, Journal of the American College of Cardiology.

[5]  P. Lambiase,et al.  A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy , 2013, Heart.

[6]  H. Chubb,et al.  The use of Z-scores in paediatric cardiology , 2012, Annals of pediatric cardiology.

[7]  J. Kaski,et al.  Hypertrophic cardiomyopathy in children , 2012, Heart.

[8]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[9]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[10]  E. Leifer,et al.  Long-Term Follow-Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Risk Factors for Adverse Arrhythmic Events , 2011, Pediatric Cardiology.

[11]  W. Dreyer,et al.  Restrictive Physiology is Associated With Poor Outcomes in Children With Hypertrophic Cardiomyopathy , 2011, Pediatric Cardiology.

[12]  A. Rynkiewicz,et al.  Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. , 2010, European heart journal.

[13]  J. Allanson,et al.  Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines , 2010, Pediatrics.

[14]  S. Colan.  Hypertrophic cardiomyopathy in childhood. , 2010, Heart failure clinics.

[15]  D. Pennell,et al.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[16]  J. Towbin,et al.  Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. , 2009, Journal of the American College of Cardiology.

[17]  B. Maron,et al.  Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2009, Circulation.

[18]  M. Ackerman,et al.  Significance of left atrial volume in patients < 20 years of age with hypertrophic cardiomyopathy. , 2008, The American journal of cardiology.

[19]  D. Holmgren,et al.  Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy. , 2008, European heart journal.

[20]  L. Sleeper,et al.  The Pediatric Cardiomyopathy Registry: 1995-2007. , 2008, Progress in pediatric cardiology.

[21]  S. Colan,et al.  Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry , 2007, Circulation.

[22]  B. Maron,et al.  Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). , 2006, The American journal of cardiology.

[23]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[24]  P. Elliott,et al.  Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy , 2006, Heart.

[25]  D. Holmgren,et al.  Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly , 2005, Cardiology in the Young.

[26]  W. Mckenna,et al.  Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy , 2005, Heart.

[27]  Harry Rakowski,et al.  Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  J. Carlin,et al.  Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study , 2005, Circulation.

[29]  J. Carlin,et al.  Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study , 2005, Circulation.

[30]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[31]  C. Tracy,et al.  American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, European heart journal.

[32]  P. Elliott,et al.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.

[33]  E John Orav,et al.  The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.

[34]  L. Alday,et al.  Clinical features of hypertrophic cardiomyopathy in the young , 2002, Cardiology in the Young.

[35]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[36]  C. Wippermann,et al.  Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe , 2000, Heart.

[37]  T. Riesenfeld,et al.  A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. , 1999, Journal of the American College of Cardiology.

[38]  P. Elliott,et al.  Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[39]  B. McCrindle,et al.  Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[40]  Kenneth L. Dulin,et al.  A Validation Study of the , 2016 .

[41]  Acc Aha Esc.  [ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden death]. , 2011, Kardiologiia.

[42]  J. Stockman.  Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry , 2009 .

[43]  R. Franklin,et al.  Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. , 1988, Journal of the American College of Cardiology.